Contact allergy to topical budesonide in nasal spray.
Jorro
G
G
Unidad de Alergia, Hospital Clinic Universitri de Valencia, Spain.
Rochina
A
A
Morales
C
C
Burchés
E
E
Peláez
A
A
D000281:Administration, Intranasal; D000328:Adult; D000336:Aerosols; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D019819:Budesonide; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D005148:Facial Dermatoses / Q000209:etiology*; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D011282:Pregnenediones / Q000009:adverse effects*
D000336:Aerosols; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011282:Pregnenediones; D019819:Budesonide